EMEA-001487-PIP01-13
Key facts
| Active substance |
Gevokizumab
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0148/2014
|
| PIP number |
EMEA-001487-PIP01-13
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of chronic non-infectious uveitis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Les Laboratoires SERVIER
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|